Sullivan Christopher Ryan (CIK 1810417) reported 20 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Sell AVTX (138 shares), Buy AVTX (18,606 shares), Sell AVTX (18,606 shares), Buy AVTX (47,000 shares), Sell AVTX (13,834 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 138 | $1,808 |
| 2026-05-11 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Buy | 18,606 | $183,827 |
| 2026-05-11 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 18,606 | $448,818 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Buy | 47,000 | $377,880 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 13,834 | $256,655 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 12,347 | $238,093 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 2,700 | $56,052 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 9,219 | $197,008 |
| 2026-05-07 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 8,900 | $200,913 |
| 2026-05-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 8,458 | $110,736 |
| 2026-05-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 8,457 | $111,853 |
| 2026-04-03 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 500 | $7,929 |
| 2026-04-03 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 7,479 | $125,841 |
| 2026-04-03 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 6,200 | $105,553 |
| 2026-04-03 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 1,780 | $31,270 |
| 2026-03-31 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Buy | 24,200 | $0 |
| 2026-03-31 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 8,241 | $114,467 |
| 2025-12-12 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 155 | $636 |
| 2025-04-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Buy | 24,200 | $0 |
| 2025-04-01 | Avalo Therapeutics, Inc. (AVTX) | Chief Financial Officer | Sell | 7,285 | $61,631 |
Source: SEC Form 4 filings · as of 2026-06-12